You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 7, April 9, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Do Silver Alloy Catheters Increase the Risk of Systemic Argyria?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Saint et al1 focus on using silver alloy urinary catheters to decrease the risk of urinary tract infection in catheterized patients. They felt it was better to use silver-coated catheters instead of antibiotic-coated catheters because of the fear that resistance to the antibiotics would develop. They did not look at potential complications from exposure to silver alloy of a mucus membrane such as the urethra. Argyria, the name of the condition that occurs when silver is deposited in the body, can be a local or systemic problem. When a mucous membrane is exposed, argyria tends to be systemic and can lead to problems such as nausea, constipation, and even loss of night vision.2

The use of silver-containing products medicinally for sinusitis or cough or as a dietary supplement has been decreasing since the 1970s, when silver was widely used in tonics and the effects were noticeable. There have been case . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.